Suggestions
John Tomaro
Senior Director Clinical Operations at Bolt Biotherapeutics, Inc.
Professional Background
John Tomaro is a seasoned leader in clinical development and operations, renowned for his commitment to advancing scientific innovation in the healthcare sector. With extensive experience in managing clinical trials across various phases, particularly Phases I-III, he has specialized knowledge in both rare diseases and oncology. His impressive portfolio includes a focus on immuno-oncology and pivotal studies involving first-in-human trials and proof-of-concept studies for adeno-associated virus (AAV)-based gene therapies and engineered cell therapies. This profound expertise has positioned him as a critical resource in the clinical development landscape, dedicated to delivering novel and transformative therapies that address unmet medical needs.
Education and Achievements
Mr. Tomaro's academic foundation is built upon solid educational credentials, as he earned his Master’s degree from the prestigious University of California, Santa Cruz. Earlier, he completed his Bachelor’s degree at the University of North Carolina at Chapel Hill, which set the stage for his successful career in clinical research and operations.
His professional trajectory is marked by a succession of leadership roles at notable biotech companies. As the Senior Director of Clinical Operations at Bolt Biotherapeutics, Inc., he has been instrumental in orchestrating complex clinical trials that utilize innovative therapeutic strategies. His previous roles as Director and Associate Director of Clinical Operations at Sangamo Therapeutics, Inc. exemplify his ability to manage high-impact projects that contribute to the advancement of genomic medicine.
Furthermore, his experience at Celgene, where he held multiple positions including Senior Clinical Trial Manager and Clinical Trial Manager, showcases his depth of industry knowledge and his capacity to drive successful trial outcomes through exceptional team leadership and operational excellence. His career also includes foundational roles at BioMarin Pharmaceutical Inc. and Quintiles, where he honed his skills in clinical research management and cross-functional teamwork.
Achievements
John Tomaro has made significant contributions to the field of clinical development, particularly through his involvement in pioneering research that leads to novel therapies within oncology and rare disease sectors. His leadership style emphasizes building cohesive teams that are driven to achieve mission-critical goals. He is recognized for his adeptness at navigating the complexities of clinical trials and steering them towards successful completion.
Throughout his career, Mr. Tomaro has not only overseen clinical operations but has also played a key role in strategically aligning the operations with the broader objectives of therapeutic development. His proactive approach and strategic mindset have led to the successful execution of clinical studies that have the potential to revolutionize treatment paradigms. His dedication to patients and relentless pursuit of scientific excellence serve as hallmarks of his professional journey. As he continues to innovate and inspire, John Tomaro firmly stands as a leader in clinical development, dedicated to making a lasting impact in the world of healthcare.